INS and COVID-19: Treatment of hyperglycemia in patients with COVID-19 has been particularly difficult as many centers have attempted to limit insulin infusions to preserve PPE and minimize health care provider exposure, as treatment with insulin infusion require hourly finger stick blood glucose checks.